Report: Growth in MA Is Associated With Lower Total Medicare Spending

Why It Matters

The research shows MA can curb overall Medicare costs, challenging assumptions that fee‑for‑service spending would be lower without it and informing policy debates on program sustainability.

Key Takeaways

• 10‑point MA penetration rise cuts per‑capita Medicare spending 1.5%.
• Adjusted for coding intensity, savings drop to 1.1% per capita.
• 2012‑2021 MA growth saved $111 billion versus 2011 baseline.
• Provider behavior shifts toward MA incentives, lowering overall costs.
• MedPAC projects MA payments exceed FFS costs by $76 billion in 2026.

Pulse Analysis

Medicare Advantage’s rapid expansion reshapes the fiscal landscape of the nation’s largest health program. From 2010 to 2024, enrollment more than doubled, pushing MA’s share of beneficiaries above the halfway mark. This growth coincides with a notable decline in per‑capita Medicare expenditures, a trend highlighted by the Elevance Health Public Policy Institute’s county‑level analysis. By comparing Medicare Advantage, fee‑for‑service, and Part D data across a decade, the study quantifies a $194 per‑person saving that narrows to $146 after accounting for higher coding intensity in MA plans.

The study’s methodology underscores the importance of risk‑adjusted metrics. When researchers applied the Medicare Payment Advisory Commission’s coding intensity correction, the savings estimate fell to 1.1% per capita, translating to $83 billion over nine years. The authors attribute these efficiencies to provider behavior that aligns with MA plan incentives—enhanced chronic‑condition management, reduced reliance on costly imaging, and tighter utilization controls. Such spillover effects appear to benefit all Medicare patients, not just those enrolled in private‑managed plans, suggesting a systemic shift toward value‑based care.

Policy implications are profound. While MedPAC warns that MA payments could outpace fee‑for‑service costs by $76 billion in 2026, the Elevance findings argue that MA’s presence may be essential for overall cost containment. Decision‑makers must weigh the dual realities of higher direct payments against the indirect savings generated through provider realignment. As the debate over Medicare’s long‑term sustainability intensifies, understanding MA’s role in driving efficiency will be critical for crafting balanced reforms that preserve beneficiary access while curbing fiscal pressure.